Locally advanced soft tissue sarcoma of the thoracic wall;SARCOME LOCALEMENT EVOLUE DE LA PAROI THORACIQUE

Bulletin du Cancer

Volumn 83, Issue 5, 1996, Pages 335-343

  Bui, N B ^a   Stockle E ^a   Coindre, J M ^a   Kantor, G ^a   Kind, M ^a   Thomas, L ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

adults; neo adjuvant chemotherapy; soft tissue sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA; MAID PROTOCOL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; SOFT TISSUE SARCOMA; THORAX WALL CANCER; BACK; CANCER INVASION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RADIATION DOSE; REVIEW; SARCOMA; SOFT TISSUE TUMOR; THORAX TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACK; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; HUMANS; IFOSFAMIDE; MAGNETIC RESONANCE IMAGING; MALE; MESNA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RADIOTHERAPY DOSAGE; SARCOMA; SOFT TISSUE NEOPLASMS; THORACIC NEOPLASMS;

EID: 0030008993     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abbatucci JS, Boulier N, de Ranieri J et al. Local control and survival in soft tissue sarcomas of the limbs, trunk walls and head and neck: a study of 113 cases. Int J Radiat Oncol Biol Phys 1986;12:579-86
2. Antman KH, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and Mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-85
3. Ball ABS, Fisher C, Pittam M, Watkins RM, Westbury G. Diagnosis of soft tissue tumours by tru-cut biopsy. Br J Surg 1990;77:756-8
4. Barth RJ, Merino MJ, Solomon D. A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue sarcoma. Surgery 1992;112: 536-43
5. Bell RS, Mahoney J, O'Sullivan B et al. Wound healing complications in soft tissue sarcoma management: Comparison of three treatment protocols. J Surg Oncol 1991; 46:190-7
6. Bell RS, O'Sullivan B, Davis A, Langer F, Cummings B, Fornasier VL. Functional outcome in patients treated with surgery and irradiation for soft tissue tumours. J Surg Oncol 1991;48:224-31
7. Bui NB, Chauvergne J, Hocke C, Durand M, Brunet R, Coindre JM. Analysis of sixty soft tissue sarcomas in adults treated with a cyclophosphamide, vincristine, doxorubicine and dacarbazine (CYVADIC) combination. Cancer Chemother Pharmacol 1985;15:82-5
8. Bui NB, Chevallier B, Chevreau C et al. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity. J Clin Oncol 1995;13: 2629-36
9. Burt M. Primary malignant tumors of the chest wall. The Memorial Sloan-Kettering cancer center experience. Chest Surg Clin North Am 1994;4:137-54
10. Cany L, Bui NB, Stöckle E, Coindre JM, Kantor G, Ravaud A. Chimiothérapie d'induction et traitement combiné conservateur des sarcomes des tissus mous de l'adulte. Bull Cancer (Paris) 1992;79:1077-85
11. Coindre JM. Intérêt pratique de l'immunohistochimie dans le diagnostic des tumeurs des tissus mous. Rev Fr Lab 1994;267:41-8
12. Coindre JM, Bui NB, Goussot JF et al. Modifications histologiques après chimiothérapie des sarcomes des tissus mous de l'adulte. Ann Pathol 1985;5:95-9
13. Coindre JM, Terrier P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study on 546 patients from the French Federation of cancers sarcoma group. J Clin Oncol 1996;14:869-77
14. Coindre JM, Trojani M, Contesso G et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-9
15. Eggermont AMM, Schraffordt Koops H, Kroon BBR et al. The european experience of TNF isolated limb perfusions for nonresectable extremity soft tissue sarcomas: 85% response rate; 87% limb salvage [Abstract]. Eur J Cancer 1995;31A(Suppl5):S47
16. Elias AD, Ryan L, Sulkes A, Collins J, Aisner JA. Response to mesna, adriamycin, ifosfamide and dacarbazine in 108 patients with metastatic or unresectable sarcomas and no prior chemotherapy. J Clin Oncol 1989;7:1208-16
17. Enneking WF. Musculoskeletal tumor surgery. New York: Churchill Livingstone, 1994
18. Enzinger FM, Weiss SW. Soft tissue tumors. Saint Louis: Mosby, 1995
19. Fédération française des centres de lutte contre le cancer. Standard, options et recommandations. Paris : Arnette Blackwell, 1995
20. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-28
21. Gaynor JJ, Tan CC, Casper ES et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 1992;10:1317-29
22. Greager JA, Patel MK, Briele HA, Walker MJ, Wood DK, Das Gupta TK. Soft tissue sarcomas of the adult thoracic wall. Cancer 1987;59:370-3
23. Jones GW, Ghouinard E, Patel M. Adjuvant adriamycin (doxorubicin) in adult patients with soft-tissue sarcomas: a systemic overview and quantitative meta-analysis. Clin Invest Med 1991;14:A-772
24. Landberg T, Chavaudra J, Dobbs J et al. Prescribing, recording and reporting photon beam therapy [abstract]. ICRU report 50. Bethesda, MD, USA, 1993
25. Lejeune F, Liénard D, Eggermont A, Schaffordt Koops H, Kroon B. Intérêt des isolations perfusions des membres dans les mélanomes et les sarcomes. Ann Chir 1995;49:9-12
26. Mandard AM, Petiot JF, Marnay J et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 1989;63:1437-51
27. Pezzi CM, Pollock RE, Evans HL et al. Preoperative chemotherapy for soft tissue sarcomas of the extremities. Ann Surg 1990;211:476-81
28. Ravaud A, Bui NB, Coindre JM et al. Adjuvant chemotherapy with CYVADIC in high risk soft tissue sarcoma: a randomized prospective trial. In: Salmon SE, ed. Adjuvant therapy of cancer VI. Philadelphia: WB Saunders, 1990: 556-66
29. Rouesse JG, Friedman S, Sevin DM et al. Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas. Cancer 1987;60:296-300
30. Russell WO, Cohen J, Enzinger F et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer 1977;40:1562-70
31. Rydholm A, Gustafson P, Rooser B, Willen H, Akerman M, Herrlin K. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991;9:1757-65
32. Santoro A, Tursz T, Mouridsen H et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for research and treatment of cancer soft tissue and bone sarcoma group. J Clin Oncol 1995;13:1537-45
33. Sastre-Garau X, Coindre JM, Leroyer A et al. Adult soft tissue sarcoma: analysis of factors predictive for a complete remission in a series of 593 cases. Cancer 1996. In press
34. Shiraki M, Enterline H, Brooks JJ, et al. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas and mesotheliomas. The Eastern Cooperative oncology group (ECOG) experience. Cancer 1989;64:484-90
35. Suit HD. The George Edelstym memorial lecture: radiation in the management of malignant soft tissue tumours. Clin Oncol R Coll Radiol 1989;1:5-10
36. Suit HD, Proppe KH, Mankin HJ, Wood WC. Preoperative radiation therapy for sarcoma of soft tissue. Cancer 1981; 47:2269-74
37. Thomas L, Delannes M, Stöckle E et al. Intra-operative interstitial Iridium brachytherapy in the management of soft tissue sarcomas: preliminary results of a feasability phase II study. Radiother Oncol 1994;33:99-105
38. Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MKB. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 1995;72:469-75
39. Weiss SW. Histological typing of soft tissue tumours. Geneva: World Health organization, 1994
40. Zapulski MM, Ryan JR, Hussein ME, Baker LH. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In: Salmon SE, ed. Adjuvant therapy of cancer VII. Philadelphia: JB Lippincott Company, 1993:385-92